Vetter ramps up global clinical manufacturing push with major US & Europe expansion
The goal is to better support drug developers as programs move from laboratory research into clinical trials
The goal is to better support drug developers as programs move from laboratory research into clinical trials
To boost compostable packaging, resin innovation, and supply chain speed
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Move amid evidence of widespread reporting gaps
Subscribe To Our Newsletter & Stay Updated